close
close
migores1

Bruker Co. (NASDAQ:BRKR) Shares sold by Public Employees Retirement Association of Colorado

Public Employees Retirement Association Of Colorado reduced its holdings in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 0.2% during the 2nd quarter, HoldingsChannel reports. The firm owned 357,499 shares of the medical research company’s stock after selling 701 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Bruker were worth $22,812,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Principal Securities Inc. purchased a new position in Bruker during the fourth quarter valued at approximately $42,000. Quadrant Capital Group LLC boosted its holdings in shares of Bruker by 89.4% during the 4th quarter. Quadrant Capital Group LLC now owns 1,392 shares of the medical research company’s stock worth $102,000 after buying an additional 657 shares during the period. shares in the last quarter. Panagora Asset Management Inc. purchased a new stake in shares of Bruker in the fourth quarter valued at about $205,000. Norges Bank acquired a new stake in shares of Bruker in the fourth quarter valued at about $74,582,000. Finally, Coldstream Capital Management Inc. purchased a new position in Bruker during the fourth quarter valued at about $209,000. Hedge funds and other institutional investors own 79.52% of the company’s shares.

Analysts set new price targets

A number of analysts have issued reports on BRKR shares. Jefferies Financial Group assumed coverage on Bruker in a research note on Monday, June 3rd. They issued a “buy” rating and a $85.00 price target for the company. TD Cowen dropped their price objective on shares of Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. Wells Fargo & Company assumed coverage on shares of Bruker in a report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 target price on the stock. Goldman Sachs Group cut their price target on shares of Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a report on Tuesday, July 9th. Finally, Citigroup decreased their price objective on Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company’s stock. Bruker currently has a consensus rating of “Moderate Buy” and an average target price of $81.40, according to data from MarketBeat.

Want more great investment ideas?

Read Bruker’s latest stock report

Bruker stock down 1.1%

Shares of Bruker stock opened at $67.54 on Friday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.75, and a current ratio of 1.65. The firm has a 50-day moving average price of $64.56 and a 200-day moving average price of $72.88. Bruker Co. it has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The company has a market cap of $9.82 billion, a PE ratio of 24.56, a price-to-earnings-growth ratio of 2.31 and a beta of 1.18.

Bruker (NASDAQ:BRKR – Get Your Free Report ) last released its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The firm had revenue of $800.70 million for the quarter, compared to the consensus estimate of $799.44 million. In the same quarter in the previous year, the business earned $0.50 EPS. The company’s quarterly revenue was up 17.4% compared to the same quarter last year. Research analysts expect Bruker Co. to post 2.61 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were issued a $0.05 dividend. This represents a dividend of $0.20 on an annualized basis and a dividend yield of 0.30%. The ex-dividend date of this dividend was Friday, August 30. Bruker’s dividend payout ratio (DPR) is currently 7.27%.

Bruker Company Profile

(Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy & Supercon Technologies.

Featured stories

Want to see what other hedge funds BRKR owns? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Bruker Co. (NASDAQ:BRKR – Free Report).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Get news and reviews for Bruker Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bruker and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Articles

Back to top button